✦ LIBER ✦

Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed

✍ Scribed by Hidetoshi Hayashi; Isamu Okamoto; Yasuko Ichikawa; Masaki Miyazaki; Hiroshige Yoshioka; Kei Kunimasa; Kazuhiko Nakagawa

Publisher: Springer
Year: 2010
Tongue: English
Weight: 296 KB
Volume: 15
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-010-0064-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine in pemetrexe

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

✍ Paolo A. Zucali; Giovanni L. Ceresoli; Isabella Garassino; Fabio De Vincenzo; Ra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND Pemetrexed‐cisplatin chemotherapy is the standard of care in the first‐line treatment of unresectable malignant pleural mesothelioma (MPM). Second‐line cytotoxic therapy is considered for a growing group of patients, but the optimal treatment has not been defined to date.

Genomic events associated with progressi

Genomic events associated with progression of pleural malignant mesothelioma

✍ Sergey V. Ivanov; Jeremy Miller; Robert Lucito; Chunlao Tang; Alla V. Ivanova; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 607 KB

## Abstract Pleural malignant mesothelioma (MM) is an aggressive cancer with a very long latency and a very short median survival. Little is known about the genetic events that trigger MM and their relation to poor outcome. The goal of our study was to characterize major genomic gains and losses as

Prospective study of combination chemoth

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

✍ Ajay Anand; Abhay Anand; Namrata Anand 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

mainly located within the cell processes but not within perikarya. The findings thus mimicked those of classic, pediatric neuroblastoma~.~ In contrast, dense core or neurosecretory-type granules in SITA resemble those of enterochromaffin (endocrine) cells of the digestive tract. They are aggregated

Prospective study of combination chemoth

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

✍ Dong M. Shin; Frank V. Fossella; Theera Umsawasdi; William K. Murphy; Marvin H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

High doses of intrapleural cisplatin in

High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses

✍ Roberto Lerza; Mauro Esposito; Maria Vannozzi; Giovan Battista Bottino; Giuseppe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 924 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo